MERCEDES FERNANDEZ: Open Payments
NPI 1801162722 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,808 in 163 payments from 23 companies in 2025. Trend: 2023 $3,948 · 2024 $3,697 · 2025 $3,808
Food & beverage: $3,808
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 26 | $537 |
| AstraZeneca Pharmaceuticals LP | 18 | $433 |
| HARMONY BIOSCIENCES LLC | 13 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $287 |
| Grifols USA, LLC | 11 | $282 |
| Verona Pharma, Inc. | 16 | $266 |
| Regeneron Healthcare Solutions, Inc. | 7 | $196 |
| GENZYME CORPORATION | 6 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $162 |
| Inspire Medical Systems, Inc. | 3 | $159 |
Products named: DUPIXENT, NUCALA, WAKIX, Prolastin-C Liquid, Ohtuvayre, GLASSIA, TEZSPIRE, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
